日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A 5-Br-1-Propylisatin Derivative as a Promising BRD9 Ligand: Insights from Computational and STD NMR Investigation

5-溴-1-丙基异靛红衍生物作为一种有前景的BRD9配体:来自计算和STD NMR研究的见解

Gazzillo, Erica; Rocha, Gabriel; Chini, Maria Giovanna; Lauro, Gianluigi; Angulo, Jesús; Bifulco, Giuseppe

BRD9 at the crossroads of splicing, chromatin remodeling, and hematopoiesis

BRD9 处于剪接、染色质重塑和造血的十字路口

Yamasaki, Takaya; Nishimura, Koutarou; Inoue, Daichi

The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects

BRD9在癌症中的双重作用:机制解析与治疗前景

Li, Jingxuan; Dai, Wei; Cao, Fuqiang; Hou, Wen; Zhou, Xuan; Liang, Wan; Xie, Fenfen; Fu, Yue; Xie, Zhongqi; Liu, Shenglan

Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells.

通过虚拟筛选和细胞验证,发现多替拉韦作为 BRD9 抑制剂可减轻腹膜间皮细胞的焦亡。

Gai Junfang, Xing Xiaohong, Gong Chanjuan, Teng Yanjuan, Chen Shunjie, Yang Ming, Lou Weijuan

BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer.

BRD9-p53-E2F1回路调控胃癌细胞生长和DNA损伤修复。

Zhou Qingqing, Wang Qi, Duan Yantao, Zhang Chi, Liu Tengfei, Liu Hengrui, Zhao Mindi, Hu Zhihuang

Depletion of BRD9-mediated R-loop accumulation inhibits leukemia cell growth via transcription-replication conflict

BRD9介导的R环积累减少可通过转录-复制冲突抑制白血病细胞生长。

Seo Yun Lee ,Soo Hyeon Lee ,Min Jae Kwak ,Ja Young Kim ,Jullian O Perren ,Kyle M Miller ,Jae Jin Kim

Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9

能够选择性降解BRD9的DCAF16募集靶向胶的作用机制

Scott J Hughes ,Wojciech J Stec ,Colin T R Davies ,David McGarry ,Alicia Williams ,Marta Carrara ,Ivan Del Barco Barrantes ,Rebecca Harris ,Anna Tasegian ,Dominic D G Owens ,Alexander Fawcett ,John Hellicar ,Aleksandra Azevedo ,Gregor P Meier ,Andrew C Runcie ,Liliana Greger ,Martin O'Rourke ,Ian Churcher ,Martin Pass ,Giles A Brown ,Alessio Ciulli ,Louise K Modis ,Andrea Testa

Key imidazolyl groups that induce phenylalanine flipping enhance the efficacy of oral BRD9 inhibitors for AML treatment

诱导苯丙氨酸翻转的关键咪唑基团可增强口服BRD9抑制剂治疗急性髓系白血病(AML)的疗效。

Chen, Zhiming; Zhang, Cheng; Shen, Hui; Xu, Hongrui; Huang, Yumin; Dong, Ruibo; Tang, Xin; Chai, Shuang; Li, Junhua; Xu, Jinxin; Zhang, Xiaohan; Zhang, Yan; Wu, Xishan; Xu, Yong

New leap of BRD9 inhibitor: Imidazole substituents making BRD9 inhibitors excellent drug candidates for AML

BRD9抑制剂的新突破:咪唑取代基使BRD9抑制剂成为治疗急性髓系白血病(AML)的优良候选药物。

Zhou, Edward

BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma

BRD9抑制剂克服胶质母细胞瘤溶瘤病毒治疗耐药性

Chen Guo,Zhilin Long,Peng Lin,Yinan Shen,Yiye Zhong,Jingjing Qian,Jichuan Yu,Weixi Zhao,Fuyi Liu,Yiling Ma,Jian Zheng,Jiayao Yang,Shuai Zhao,Xiaojuan Ran,Zhen Xia,Congying Wu,Yujia Cai,Chen Wang,Qi Xie